Skip to main content

Table 3 Acute toxicity of concurrent cisplatin with hypofractionation (HYP-UK) for locally advanced head and neck cancer. According to the Common Terminology Criteria for Adverse Events Version 3.0

From: Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma

Acute adverse event Grade 1/2 Grade 3 Grade 4
n (%) n (%) n (%)
Hematological
 Anemia 7 (35) 0 0
 Lymphopenia 7 (35) 3 (15) 1 (5)
 Thrombocytopenia 1 (5) 0 0
 Neutropenia 5 (25) 1 (5) 0
 Febrile Neutropenia 0 1(5) 0
Non-Hematological
 Radiodermatitis 19 (95) 6 (30) 0
 Mucositis 15 (75) 8 (40) 0
 Increased serum creatinine 1 (5) 0 0